NORTH BAY VILLAGE, Fla.--(BUSINESS WIRE)--Gary Macleod, NIMS Chief Executive Officer, announced that, “Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) has entered into a Product and Development and Supply Agreement with SingLin Technology, Ltd. (SingLin), Taichung, Taiwan. According to NIMS’ specifications, SingLin will manufacture NIMS’ patented Exer-Rest™ motorized platform that moves a supine subject repetitively head to foot about 140 times per minute. This motion platform has the appearance and functionality of either a cot or twin bed in standard and extra-long dimensions. Exer-Rest is currently being tested in a controlled pilot study for temporary relief of musculoskeletal pain associated with osteoarthritis of the hip(s) prior to the launch of a pivotal trial to be submitted to FDA for approval to market in the United States. The Exer-Rest will be marketed and sold in the Canada, UK, Europe, South America and India by NIMS and in the Far East by SingLin. NIMS will receive a royalty on each device sold by SingLin.”
